Pegloticase 8 MG/ML [Krystexxa]

DRUG2 trials

Sponsors

University of Alabama at Birmingham, University of Colorado, Denver

Conditions

DiabetesDiabetes ComplicationsDiabetes Mellitus, Type 2Diabetic Kidney DiseaseDiabetic NephropathiesGout ChronicHyperuricemiaType 2 Diabetes Mellitus

Phase 2

REduCing Immunogenicity to PegloticasE (RECIPE) Study

CompletedNCT03303989

University of Alabama at BirminghamGout Chronic

Start: 2018-06-14End: 2021-03-31Updated: 2022-03-16

Uric Acid Lowering Trial in Youth Onset T2D

CompletedNCT03899883

University of Colorado, DenverDiabetes, Diabetes Complications, Diabetes Mellitus, Type 2 +5

Start: 2020-01-01End: 2023-04-13Updated: 2026-07-28